S

Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506

Watchlist Manager
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Watchlist
Price: 283.88 CNY 0.94% Market Closed
Market Cap: 113.8B CNY

Intrinsic Value

Sichuan Biokin Pharmaceutical Co Ltd's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one Sichuan Biokin Pharmaceutical Co Ltd stock under the Base Case scenario is 12.11 CNY. Compared to the current market price of 283.88 CNY, Sichuan Biokin Pharmaceutical Co Ltd is Overvalued by 96%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
12.11 CNY
Overvaluation 96%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation History
Sichuan Biokin Pharmaceutical Co Ltd

What is Valuation History?
Compare Sichuan Biokin Pharmaceutical Co Ltd to

Fundamental Analysis

Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
CN
Pharmaceuticals
Market Cap
113.8B CNY
IPO
Jan 6, 2023
CN
Pharmaceuticals
Market Cap
113.8B CNY
IPO
Jan 6, 2023
Price
ÂĄfalse
EPS
ÂĄfalse
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Sichuan Biokin Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Sichuan Biokin Pharmaceutical Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sichuan Biokin Pharmaceutical Co Ltd

Current Assets 6.3B
Cash & Short-Term Investments 5.8B
Receivables 255m
Other Current Assets 299.1m
Non-Current Assets 830.2m
Long-Term Investments 1.3m
PP&E 573.1m
Intangibles 26.7m
Other Non-Current Assets 229m
Efficiency

Free Cash Flow Analysis
Sichuan Biokin Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Sichuan Biokin Pharmaceutical Co Ltd

Revenue
428m CNY
Cost of Revenue
-248.7m CNY
Gross Profit
179.3m CNY
Operating Expenses
-2.1B CNY
Operating Income
-1.9B CNY
Other Expenses
86m CNY
Net Income
-1.8B CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Sichuan Biokin Pharmaceutical Co Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Strong 3Y Average Gross Margin
Healthy Gross Margin
Negative 3Y Average Net Margin
37/100
Profitability
Score

Sichuan Biokin Pharmaceutical Co Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Sichuan Biokin Pharmaceutical Co Ltd's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Negative Net Debt
Low D/E
76/100
Solvency
Score

Sichuan Biokin Pharmaceutical Co Ltd's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Sichuan Biokin Pharmaceutical Co Ltd

Wall Street analysts forecast Sichuan Biokin Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Sichuan Biokin Pharmaceutical Co Ltd is 310.58 CNY with a low forecast of 302.39 CNY and a high forecast of 330.4 CNY.

Lowest
Price Target
302.39 CNY
7% Upside
Average
Price Target
310.58 CNY
9% Upside
Highest
Price Target
330.4 CNY
16% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Sichuan Biokin Pharmaceutical Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for Sichuan Biokin Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Sichuan Biokin Pharmaceutical Co Ltd stock?

The intrinsic value of one Sichuan Biokin Pharmaceutical Co Ltd stock under the Base Case scenario is 12.11 CNY.

Is Sichuan Biokin Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 283.88 CNY, Sichuan Biokin Pharmaceutical Co Ltd is Overvalued by 96%.

Back to Top